Perimed

11/01/1989 - "Efficacy of Perimed antibacterial system on established gingivitis. "
11/01/1989 - "It was concluded that the use of Perimed could be a beneficial adjunctive treatment for the prevention and control of gingivitis when used with routine oral hygiene procedures."
11/01/1989 - "A 6-month, double-blind controlled study was conducted on 101 subjects to determine the effect of Perimed antibacterial system, containing povidone-iodine (PVP-I) and hydrogen peroxide (H2O2), on established gingivitis. "
01/01/1992 - "We concluded that both Peridex and Perimed were effective in reducing plaque and gingivitis when used as a 2 x daily mouthrinse by subjects refraining from other oral hygiene procedures. "
01/01/1992 - "The aim of this study was to evaluate the effect of 3 mouthrinses, Listerine Antiseptic (thymol), Peridex (chlorhexidine), Perimed (povidone iodine and hydrogen peroxide), and a placebo (water) on the development of dental plaque and gingivitis, when used as the only oral hygiene procedure for 14 days. "

05/24/2022 - "In this study, we assessed the ability of the EPOS system (Perimed AB, Järfälla, Stockholm, Sweden) to detect differences in tissue perfusion between healthy volunteers and patients with peripheral arterial disease (PAD) with different severity of disease. "

01/01/1996 - "We conducted a study in 15 controls (mean age 49.5 yrs, 30 limbs) and 37 patients with peripheral arterial occlusive disease (PAOD) (mean age 59.1 yrs, 67 limbs, 50 mild ischemia and 17 severe ischemia) and assessed the local blood flow with laser-Doppler (Perimed PF3) and transcutaneous oximetry (Hellige Oxymonitor); both probes being heated at 44 degrees C. "

01/01/1992 - "The aim of this study was to evaluate the effect of 3 mouthrinses, Listerine Antiseptic (thymol), Peridex (chlorhexidine), Perimed (povidone iodine and hydrogen peroxide), and a placebo (water) on the development of dental plaque and gingivitis, when used as the only oral hygiene procedure for 14 days. "

01/01/1996 - "We conducted a study in 15 controls (mean age 49.5 yrs, 30 limbs) and 37 patients with peripheral arterial occlusive disease (PAOD) (mean age 59.1 yrs, 67 limbs, 50 mild ischemia and 17 severe ischemia) and assessed the local blood flow with laser-Doppler (Perimed PF3) and transcutaneous oximetry (Hellige Oxymonitor); both probes being heated at 44 degrees C. "